European Central Bank President Lagarde: The decline in corporate profit margins is due to the increase in the cost of absorbing labor. European Central Bank President Lagarde: It is observed that corporate profit margins have declined. Inflation risk is not a two-way street. The prospect of economic productivity is improving. The decline in profit margin is due to the increase in the cost of absorbing labor.European Central Bank President Lagarde: Regardless of the market pricing of interest rate hikes, European Central Bank President Lagarde said that the European Central Bank will adjust its policies according to the data and will decide the policies of each meeting one by one. The neutral interest rate cannot be accurately determined without considering the market pricing of interest rate hikes.Spot gold fell 1% to $2,690.81. COMEX silver futures fell 1.5% in the day to $32.47 per ounce.
European Central Bank President Lagarde: Economic growth is losing momentum.Australia plans to force technology giants to pay for news content. The Australian government announced a new tax plan on the 12th, which will force technology giants to pay for news content to Australian media companies, otherwise they will face the risk of being charged higher taxes. According to the Australian government's plan, all digital platforms with an annual income of more than A $250 million (about US$ 160 million) in Australia must reach a commercial agreement with Australian media organizations on the use of news content, otherwise they will face the risk of being charged higher taxes. (Xinhua News Agency)According to HKEx documents, iFLYTEK Medical Technology Co., Ltd. passed the listing hearing of HKEx.
European Central Bank President Lagarde: Protectionism will lead to short-term inflation. European Central Bank President Lagarde: Protectionism will lead to short-term inflation. Higher tariffs may lead to inflation in the short term; The final impact of high tariffs on inflation is uncertain.Baiyang Pharmaceutical Group signed an agreement with Peking University Hospital. On December 12, Baiyang Pharmaceutical Group signed a cooperation agreement with Peking University No.1 Hospital, and obtained the exclusive right to patent, clinical development and registration, production and marketing of "targeted integrin small molecule inhibitor" in Peking University Hospital.NATO Secretary General Rutte: We will need to spend far more than 2% of GDP on national defense.
Strategy guide
Strategy guide